Rhythm Biosciences Limited (ASX:RHY)
Australia
· Delayed Price · Currency is AUD 0.202
+0.002 (1.00%)
Mar 10, 2026, 11:51 AM AEST
Rhythm Biosciences Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2017 |
| Net Income | -6.68 | -3.83 | -6.86 | -8.22 | -8.79 | -6.61 | Upgrade
|
| Depreciation & Amortization | 0.2 | 0.2 | 0.2 | 0.19 | 0.1 | 0.15 | Upgrade
|
| Stock-Based Compensation | 0.35 | 0.35 | -1.05 | 3 | 2.61 | 0.56 | Upgrade
|
| Other Operating Activities | -0.35 | -0 | - | - | - | - | Upgrade
|
| Change in Accounts Receivable | 0.38 | 0.38 | -1.03 | 0.91 | -0.48 | -0.04 | Upgrade
|
| Change in Inventory | 0.01 | 0.01 | 2.77 | -2.77 | - | - | Upgrade
|
| Change in Accounts Payable | - | - | - | - | - | 0.51 | Upgrade
|
| Change in Other Net Operating Assets | -0.04 | -0.04 | -0.16 | -0.08 | 0.07 | 0.04 | Upgrade
|
| Operating Cash Flow | -6.11 | -2.92 | -6.14 | -6.96 | -6.5 | -5.4 | Upgrade
|
| Capital Expenditures | -0.02 | -0.02 | -0.08 | -0.1 | -0.03 | -0.07 | Upgrade
|
| Cash Acquisitions | - | -0.52 | - | - | - | - | Upgrade
|
| Investment in Securities | 0.04 | - | - | - | - | - | Upgrade
|
| Other Investing Activities | -0.04 | -0.04 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -0.02 | -0.58 | -0.08 | -0.1 | -0.03 | -0.07 | Upgrade
|
| Short-Term Debt Issued | - | 2.15 | - | - | - | - | Upgrade
|
| Total Debt Issued | 1 | 2.15 | - | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -1.15 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.09 | -0.09 | -0.09 | -0.01 | -0.04 | Upgrade
|
| Total Debt Repaid | -1.16 | -1.24 | -0.09 | -0.09 | -0.01 | -0.04 | Upgrade
|
| Net Debt Issued (Repaid) | -0.16 | 0.91 | -0.09 | -0.09 | -0.01 | -0.04 | Upgrade
|
| Issuance of Common Stock | 3.75 | 3.5 | 3.02 | 3.74 | 12.32 | 6.17 | Upgrade
|
| Other Financing Activities | -0.18 | -0.22 | -0.12 | -0.02 | -0.47 | -0.23 | Upgrade
|
| Financing Cash Flow | 3.41 | 4.19 | 2.8 | 3.63 | 11.85 | 5.9 | Upgrade
|
| Net Cash Flow | -2.73 | 0.69 | -3.41 | -3.43 | 5.32 | 0.43 | Upgrade
|
| Free Cash Flow | -6.14 | -2.94 | -6.22 | -7.06 | -6.52 | -5.47 | Upgrade
|
| Free Cash Flow Margin | -372.52% | -92.25% | -367.98% | -227.94% | -268.74% | -493.52% | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.01 | -0.03 | -0.03 | -0.03 | -0.03 | Upgrade
|
| Cash Interest Paid | 0.08 | 0.07 | 0 | 0.01 | - | 0 | Upgrade
|
| Cash Income Tax Paid | - | -3.17 | -1.69 | -3.08 | -2.41 | -1.11 | Upgrade
|
| Levered Free Cash Flow | -3.93 | -1.48 | -3.63 | -4.12 | -3.28 | -2.97 | Upgrade
|
| Unlevered Free Cash Flow | -3.88 | -1.43 | -3.63 | -4.12 | -3.28 | -2.97 | Upgrade
|
| Change in Working Capital | 0.36 | 0.36 | 1.57 | -1.93 | -0.41 | 0.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.